Advertisement
Reform Update: Ascension Health bars Genentech sales reps from its hospitals

Reform Update: Ascension Health bars Genentech sales reps from its hospitals

By Bob Herman  |  October 02, 2014

Pharmaceutical giant Genentech has come under a maelstrom of criticism from hospitals for its decision to change its distribution methods for three widely used cancer drugs, and now the nation's largest not-for-profit health system is responding with a bold message.

Pathologists to weigh challenges of new molecular tests

By Jaimy Lee  |  September 06, 2014

The related issues of healthcare costs and the appropriateness of molecular and genetic testing will be considered by pathologists attending the annual meeting this week of the College of American Pathologists.

Highmark alleges UPMC overcharged for cancer care

By Bob Herman  |  September 05, 2014

As one fight between Pittsburgh's two healthcare giants simmers, another has begun. Insurer Highmark filed a fresh lawsuit against UPMC alleging the hospital system has charged exorbitant prices for cancer drugs and services. Highmark said UPMC's billing strategy has resulted in $300 million in...

Billionaire doc Soon-Shiong's next goal: redefine cancer care

Billionaire doc Soon-Shiong's next goal: redefine cancer care

By Bob Herman  |  August 06, 2014

Dr. Patrick Soon-Shiong is one of the most well-known surgeons in healthcare. He's worth billions of dollars, thanks to several medical and pharmaceutical breakthroughs. He's also a minority owner of the NBA's Los Angeles Lakers. So why has he decided to take a job with Renton, Wash.-based...

Researchers affirm cancer risk of common uterine procedure

Researchers affirm cancer risk of common uterine procedure

By Jaimy Lee  |  July 22, 2014

About 1 of every 370 women who underwent a minimally invasive hysterectomy using morcellation was found to have uterine cancer, a finding that is consistent with data that the Food and Drug Administration put out this month.

Advertisement